Chris Brinzey

Managing Director

Chris brings over 20 years of experience working within the financial services industry to ICR Capital. During this time Chris has worked both as a sell-side and a buy-side analyst. Before joining ICR Capital, Chris was a Managing Director at Westwicke Partners providing capital markets advisory services to the firm’s healthcare clients. Prior to Westwicke, Chris was a Senior Vice President of Research and a member of the Portfolio Management team at Tekla Capital Management (formerly Hambrecht & Quist Capital Management), which manages $2.5 billion in assets and is focused on investing in both public and private healthcare companies. At Tekla, Chris’ responsibilities included in-depth industry coverage of public companies within multiple healthcare sectors including biotech, specialty pharmaceuticals, and the healthcare services area. Responsibilities at Tekla also included working with private companies both as a Member of the Board as well as a Board Observer helping portfolio companies refine corporate strategies, assist in fundraising, and provide Board oversight of corporate exits (trade sales or IPOs).

Prior to working at Tekla Capital Management, Chris was a Vice President at Advest, a full-service regional investment bank, where he was hired to be the senior publishing analyst covering the Healthcare Information Technology and Services sector. At Advest, Chris was responsible for starting the healthcare information technology practice and publishing thematic and monthly industry and company reports on the Healthcare Information Technology sector, including thought-leadership pieces on internet and mobile healthcare technologies.

Chris earned an MBA from Northeastern University and holds a BA in psychology from Hobart College. He lives just south of Boston, Massachusetts with his wife and three girls.